Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2025-12-30 @ 4:31 PM
Study NCT ID:
NCT04521803
Status:
RECRUITING
Last Update Posted:
2025-08-21
First Post:
2020-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
Sponsor:
University of Cape Town
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-16
First Submit QC Date:
None
Study First Post Date:
2020-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-15
Last Update Post Date:
2025-08-21
Last Update Post Date Type:
ACTUAL